Top compounds associated with response to C2orf69


Feature Type Standardized
Nominal ANOVA
mRNA TGX221 CTRPv2 pan-cancer AAC -0.074 0.05
mRNA semagacestat CTRPv2 pan-cancer AAC -0.074 0.05
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.05
mRNA Gemcitabine gCSI pan-cancer AAC 0.11 0.05
mRNA PLX4720 CCLE pan-cancer AAC 0.084 0.05
mRNA YM201636 GDSC1000 pan-cancer AAC 0.059 0.05
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.055 0.06
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.06
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.064 0.06
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.14 0.06
Download CSV